Cargando…
Relationship between serum osteoprotegerin and vascular calcifications in hemodialysis patients
BACKGROUND: Uremia is a vasculopathic process, and both cardiac calcification and vascular calcification seen from the early stages of chronic kidney disease. Osteoprotegerin could play a crucial role in atherosclerotic plaque formation, maturation and calcification. The goal of this study was to de...
Autores principales: | El Baz, Tarek Z., Khamis, Osama A., El-Shehaby, Amal, Chahine, Hussein, Alaa Al-Din Ahmed, Ahmad, Alsawasany, Mostafa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Egyptian Society of Cardiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839346/ https://www.ncbi.nlm.nih.gov/pubmed/29622969 http://dx.doi.org/10.1016/j.ehj.2017.02.004 |
Ejemplares similares
-
The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation Markers
por: NasrAllah, Mohamed M., et al.
Publicado: (2013) -
Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes
por: Aoki, Atsushi, et al.
Publicado: (2013) -
Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients
por: Lee, Jung Eun, et al.
Publicado: (2013) -
Association of Serum Osteoprotegerin Level With Myocardial Injury and Cardiovascular Calcification in Chronic Kidney Disease Patients
por: Okasha, Kamal M., et al.
Publicado: (2022) -
Cardiovascular risk of circulating endotoxin level in prevalent hemodialysis patients
por: Ibrahim, Mohamed, et al.
Publicado: (2018)